U.S. Apellis Pharmaceuticals, Energizer Holdings, Walmart
Nov 20 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apellis Pharmaceuticals, Energizer Holdings and Walmart, on Wednesday.
HIGHLIGHTS
* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $50 from $57 |
* Chord Energy Corp CHRD.O: RBC cuts target price to $180 from $185 |
* Energizer Holdings Inc ENR.N: JP Morgan raises to neutral from underweight |
* Salesforce Inc CRM.N: JP Morgan raises target price to $340 from $310 |
* Walmart WMT.N: Telsey Advisory Group raises target price to $100 from $92 |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* AECOM ACM.N: RBC raises target price to $124 from $113 |
* Aerovironment Inc AVAV.O: Jefferies cuts target price to $230 from $240 |
* Aerovironment Inc AVAV.O: Jefferies raises to buy from hold |
* AGNC Investment Corp AGNC.O: UBS cuts target price to $9.75 from $10.25 |
* Allison Transmission Holdings Inc ALSN.N: Citigroup raises target to $125 from $115 |
* Annexon Inc ANNX.O: JP Morgan cuts target price to $9 from $11 |
* APA Corporation APA.O: Mizuho cuts target price to $25 from $28 |
* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $50 from $57 |
* Applovin Corp APP.O: Piper Sandler initiates coverage with overweight rating; target $400 |
* Applovin Corp APP.O: Wells Fargo raises target price to $360 from $250 |
* Arbutus Biopharma Corp ABUS.O: Chardan Capital Markets raises PT to $5 from $4.50 |
* Armour Residential REIT Inc ARR.N: UBS cuts target price to $19.50 from $20.50 |
* ARQ Inc ARQ.O: Canaccord Genuity initiates coverage with buy rating; PT $10 |
* Arthur J. Gallagher & Co AJG.N: Barclays raises target price to $308 from $300 |
* Arvinas Inc ARVN.O: BMO cuts target price to $88 from $90 |
* Azek Company Inc AZEK.N: Barclays raises target price to $58 from $53 |
* Azek Company Inc AZEK.N: BMO raises target price to $51 from $49 |
* Azek Company Inc AZEK.N: D.A. Davidson raises target price to $50 from $44 |
* Azek Company Inc AZEK.N: Jefferies cuts target price to $56 from $57 |
* Azek Company Inc AZEK.N: RBC raises target price to $50 from $46 |
* Azek Company Inc AZEK.N: Truist Securities raises target price to $57 from $52 |
* Azek Company Inc AZEK.N: UBS raises target price to $49 from $43 |
* Bank of America BAC.N: Oppenheimer raises target price to $57 from $56 |
* Bellring Brands BRBR.N: Deutsche Bank raises target price to $77 from $73 |
* Bellring Brands BRBR.N: JP Morgan raises target price to $84 from $64 |
* Bellring Brands BRBR.N: Mizuho raises target price to $80 from $72 |
* Bellring Brands BRBR.N: Stifel raises target price to $81 from $67 |
* Bellring Brands BRBR.N: TD Cowen raises target price to $83 from $75 |
* Bellring Brands BRBR.N: Truist Securities raises target price to $75 from $60 |
* Berry Global Group Inc BERY.N: Baird raises target price to $70 from $65 |
* Berry Global Group Inc BERY.N: Truist Securities cuts target price to $72 from $74 |
* Bridgebio pharma Inc BBIO.O: JP Morgan cuts target price to $40 from $43 |
* Brown & Brown Inc BRO.N: Barclays raises target price to $119 from $108 |
* Brown-Forman BFb.N: Deutsche Bank cuts target price to $42 from $44 |
* Campbell Soup Co CPB.O: Jefferies cuts target price to $46 from $52 |
* Caseys General Stores Inc CASY.O: JP Morgan raises target price to $338 from $337 |
* Centene CNC.N: Deutsche Bank cuts target price to $84 from $87 |
* Chewy Inc CHWY.N: BofA Global Research raises price objective to $40 from $24 |
* Chewy Inc CHWY.N: BofA Global Research raises to buy from underperform |
* Chord Energy Corp CHRD.O: RBC cuts target price to $180 from $185 |
* Cingulate Inc CING.O: Maxim Group raises to buy from hold |
* Cisco Systems CSCO.O: Deutsche Bank raises target price to $57 from $53 |
* Citigroup Inc C.N: Oppenheimer raises target price to $110 from $107 |
* Corteva CTVA.N: BofA Global Research raises price objective to $69 from $67 |
* Corteva CTVA.N: Citigroup raises target price to $70 from $67 |
* Corteva CTVA.N: Wells Fargo raises target price to $67 from $65 |
* Crowdstrike CRWD.O: Stifel raises target price to $375 from $300 |
* Cummins CMI.N: Citigroup raises target price to $415 from $375 |
* CVS Health Corp CVS.N: Truist Securities cuts target price to $67 from $76 |
* Danimer Scientific Inc DNMR.N: Jefferies raises target price to $7 from $0.40 |
* Danimer Scientific Inc DNMR.N: Piper Sandler cuts target price to $4 from $40 |
* Danimer Scientific Inc DNMR.N: Piper Sandler cuts to underweight from neutral |
* DMC Global Inc BOOM.O: Stifel cuts target price to $8 from $16 |
* DMC Global Inc BOOM.O: Stifel cuts to hold from buy |
* Dolby Laboratories DLB.N: Rosenblatt Securities raises target price to $100 from $98 |
* Dyne Therapeutics DYN.O: JP Morgan cuts target price to $34 from $35 |
* Dynex Capital Inc DX.N: UBS cuts target price to $12.50 from $13.50 |
* Energizer Holdings Inc ENR.N: JP Morgan raises target price to $39 from $32 |
* Energizer Holdings Inc ENR.N: JP Morgan raises to neutral from underweight |
* Energizer Holdings Inc ENR.N: Truist Securities raises target price to $45 from $40 |
* Energizer Holdings Inc ENR.N: UBS raises target price to $39 from $33 |
* Energizer Holdings Inc ENR.N: Morgan Stanley raises target price to $36 from $33 |
* Equifax Inc EFX.N: Stifel cuts target price to $284 from $305 |
* Equinix EQIX.O: Deutsche Bank raises target price to $960 from $915 |
* Equinix EQIX.O: Stifel raises target price to $1,080 from $995 |
* Finance of America Companies Inc FOA.N: UBS cuts to neutral from buy |
* Finance of America Companies Inc FOA.N: UBS raises target price to $24 from $14 |
* First Advantage FA.O: Barclays reinstates coverage with overweight rating; target $22 |
* Firstsun Capital Bancorp FSUN.O: Raymond James raises to outperform from market perform |
* Foot Locker Inc FL.N: UBS cuts target price to $26 from $29 |
* Fortinet Inc FTNT.O: Rosenblatt Securities raises target price to $100 from $90 |
* Fortinet Inc FTNT.O: Scotiabank raises target price to $110 from $85 |
* Fortinet Inc FTNT.O: Truist Securities raises target price to $105 from $85 |
* Gaming and Leisure Properties Inc GLPI.O: Deutsche Bank raises target to $54 from $49 |
* Gaming and Leisure Properties Inc GLPI.O: Deutsche Bank raises to buy from hold |
* Globalfoundries Inc GFS.O: UBS initiates coverage with neutral rating and target price $47 |
* Goldman Sachs Group GS.N: Oppenheimer raises target price to $677 from $661 |
* Goosehead Insurance Inc GSHD.O: BMO raises target price to $145 from $120 |
* Goosehead Insurance Inc GSHD.O: TD Cowen raises target price to $130 from $94 |
* Helmerich & Payne Inc HP.N: Barclays cuts target price to $36 from $39 |
* Hess HES.N: Mizuho raises target price to $199 from $194 |
* HP Inc HPQ.N: JP Morgan cuts target price to $41 from $42 |
* I3 Verticals Inc IIIV.O: Raymond James raises target price to $30 from $28 |
* Ingram Micro Holding INGM.N: JP Morgan initiates coverage with neutral rating; PT $28 |
* Inspire Medical Systems Inc INSP.N: BofA Global Research raises price objective to $255 from $220 |
* Inspire Medical Systems Inc INSP.N: BofA Global Research raises to buy from neutral |
* Invesco Mortgage Capital Inc IVR.N: UBS cuts target price to $8.5 from $9 |
* Invivyd Inc IVVD.O: Morgan Stanley cuts target price to $3.55 from $9.50 |
* Jack in the Box Inc JACK.O: Guggenheim cuts target price to $60 from $95 |
* Jacobs Solutions Inc J.N: Benchmark cuts to hold from buy |
* Jacobs Solutions Inc J.N: Citigroup cuts target price to $161 from $166 |
* Jefferies Financial Group Inc. JEF.N: Oppenheimer cuts target price to $82 from $83 |
* JP Morgan Chase & Co JPM.N: Oppenheimer cuts to perform from outperform |
* Keysight Technologies KEYS.N: Deutsche Bank raises target price to $180 from $175 |
* Keysight Technologies KEYS.N: Barclays raises target price to $200 from $180 |
* Keysight Technologies KEYS.N: BofA Global Research raises price objective to $160 from $150 |
* Keysight Technologies Inc KEYS.N: JP Morgan raises target price to $170 from $165 |
* Keysight Technologies Inc KEYS.N: Morgan Stanley raises target to $180 from $165 |
* Kinder Morgan Inc KMI.N: BofA Global Research raises price objective to $28 from $27 |
* Kyverna Therapeutics Inc KYTX.O: H.C. Wainwright cuts target price to $6 from $7 |
* Labcorp LH.N: Mizuho raises target price to $264 from $256 |
* Lemonade Inc LMND.N: Morgan Stanley raises target price to $42 from $23 |
* Lemonade Inc LMND.N: Morgan Stanley raises to equal-weight from underweight |
* Lowe's Companies Inc LOW.N: Barclays raises target price to $245 from $229 |
* Lowe's Companies Inc LOW.N: Bernstein cuts target price to $301 from $306 |
* Lowe's Companies Inc LOW.N: D.A. Davidson raises target price to $270 |
* Lowe's Companies Inc LOW.N: HSBC raises target price to $262 from $260 |
* Lowe's Companies Inc LOW.N: Jefferies raises target price to $301 from $274 |
* Lowe's Companies Inc LOW.N: Mizuho raises target price to $282 from $280 |
* Lowe's Companies Inc LOW.N: RBC raises target price to $291 from $290 |
* Lowe's Companies Inc LOW.N: Truist Securities raises target price to $310 from $307 |
* Lowe's Companies Inc LOW.N: UBS raises target price to $300 from $290 |
* Marsh & Mclennan MMC.N: Barclays raises target price to $246 from $236 |
* Monopar Therapeutics Inc MNPR.O: Jonestrading raises target price to $37 from $9 |
* MPLX LP MPLX.N: BofA Global Research raises price objective to $46 from $43 |
* Netflix Inc NFLX.O: Pivotal Research raises target price to $1,100 from $925 |
* Neurogene Inc NGNE.O: BMO cuts target price to $45 from $60 |
* Northern Oil and Gas Inc NOG.N: RBC cuts to sector perform from outperform |
* Northern Oil and Gas Inc NOG.N: RBC raises target price to $45 from $43 |
* Nuvalent Inc NUVL.O: JP Morgan cuts target price to $121 from $125 |
* Oaktree Specialty Lending Corp OCSL.O: JP Morgan cuts PT to $15 from $17 |
* Oaktree Specialty Lending Corp OCSL.O: JP Morgan cuts to neutral from overweight |
* Oaktree Specialty Lending Corp OCSL.O: KBW cuts target price to $17 from $18 |
* Occidental Petroleum Corp OXY.N: BofA Global Research cuts price objective to $54 from $57 |
* Olema Pharmaceuticals Inc OLMA.O: JP Morgan cuts target price to $29 from $31 |
* ONEOK Inc OKE.N: BofA Global Research raises price objective to $122 from $105 |
* Openlane Inc KAR.N: JP Morgan raises target price to $23 from $21 |
* P3 Health Partners Inc PIII.O: TD Cowen cuts target price to $0.25 from $0.90 |
* Paccar Inc PCAR.O: Citigroup raises target price to $120 from $110 |
* PBF Energy Inc PBF.N: JP Morgan cuts target price to $37 from $40 |
* Penumbra Inc PEN.N: Piper Sandler raises target price to $250 from $235 |
* Provident Bancorp Inc (Maryland) PVBC.O: Stephens raises target price to $12 from $11 |
* Purecycle Technologies Inc PCT.O: TD Cowen raises target price to $15 from $10 |
* Qualcomm QCOM.O: Susquehanna cuts target price to $210 from $230 |
* RBC Bearings Inc RBC.N: Truist Securities raises target price to $347 from $315 |
* Replimune Group Inc REPL.O: JP Morgan cuts target price to $16 from $17 |
* Robinhood Markets Inc HOOD.O: Bernstein raises target price to $51 from $30 |
* Royal Caribbean Group RCL.N: Mizuho raises target price to $255 from $224 |
* Rubrik Inc RBRK.N: Barclays raises target price to $51 from $42 |
* Ryan Specialty Holdings Inc RYAN.N: Barclays raises target price to $88 from $76 |
* Salesforce Inc CRM.N: JP Morgan raises target price to $340 from $310 |
* Samsara Inc IOT.N: Morgan Stanley raises target price to $52 from $40 |
* Sarepta Therapeutics Inc SRPT.O: JP Morgan cuts target price to $197 from $202 |
* SM Energy Co SM.N: Wells Fargo raises target price to $47 from $43 |
* Springworks Therapeutics Inc SWTX.O: JP Morgan raises target price to $70 from $68 |
* Stonex Group Inc SNEX.O: Jefferies raises target price to $111 from $95 |
* Super League Enterprise Inc SLE.O: H.C. Wainwright cuts target price to $2 from $3 |
* Surgery Partners Inc SGRY.O: RBC cuts target price to $35 from $49 |
* Talkspace TALK.O: Northland Capital initiates with outperform rating; price target $5 |
* Tapestry Inc TPR.N: Barclays reinstates coverage with equal weight rating; target price $57 |
* Targa Resources Corp TRGP.N: Stifel raises target price to $224 from $190 |
* Tectonic Therapeutic TECX.O: Raymond James initiates with outperform rating; PT $65 |
* TJX Companies Inc TJX.N: JP Morgan raises target price to $127 from $126 |
* Transmedics Group Inc TMDX.O: Canaccord Genuity cuts target price to $104 from $109 |
* Transmedics Group Inc TMDX.O: Piper Sandler cuts target price to $110 from $180 |
* TransUnion TRU.N: Oppenheimer cuts target price to $115 from $122 |
* Travere Therapeutics Inc TVTX.O: JP Morgan cuts target price to $42 from $43 |
* Trinet Group Inc TNET.N: TD Cowen raises target price to $104 from $92 |
* Trubridge Inc TBRG.O: Stephens raises target price to $17 from $13 |
* Two Harbors Investment Corp TWO.N: UBS cuts target price to $14 from $15.75 |
* U.S. Bancorp USB.N: Oppenheimer raises target price to $66 from $64 |
* US Gold Corp USAU.O: H.C. Wainwright raises target price to $13 from $11 |
* Valvoline Inc VVV.N: JP Morgan cuts target price to $37 from $40 |
* Valvoline Inc VVV.N: Mizuho cuts target price to $46 from $50 |
* Valvoline Inc VVV.N: Morgan Stanley cuts target price to $42 from $46 |
* Valvoline Inc VVV.N: RBC cuts target price to $46 from $52 |
* Valvoline Inc VVV.N: Wells Fargo cuts target price to $44 from $46 |
* Vera Therapeutics Inc VERA.O: JP Morgan raises target price to $77 from $75 |
* Viasat VSAT.O: Barclays cuts target price to $9 from $24 |
* Viasat Inc VSAT.O: Barclays cuts target price to $9 from $24 |
* Viking Holdings Ltd VIK.N: Barclays raises target price to $49 from $43 |
* Vir Biotechnology Inc VIR.O: JP Morgan cuts target price to $10 from $13 |
* Walmart WMT.N: Bernstein raises target price to $102 from $98 |
* Walmart WMT.N: BofA Global Research raises price objective to $105 from $95 |
* Walmart WMT.N: D.A. Davidson raises target price to $100 from $85 |
* Walmart WMT.N: Deutsche Bank raises target price to $100 from $91 |
* Walmart WMT.N: Guggenheim raises target price to $100 from $90 |
* Walmart WMT.N: Jefferies raises target price to $105 from $100 |
* Walmart WMT.N: Raymond James raises target price to $95 from $80 |
* Walmart WMT.N: RBC raises target price to $96 from $92 |
* Walmart WMT.N: Roth MKM raises target price to $97 from $81 |
* Walmart WMT.N: Stifel raises target price to $89 from $85 |
* Walmart WMT.N: TD Cowen raises target price to $100 from $90 |
* Walmart WMT.N: Telsey Advisory Group raises target price to $100 from $92 |
* Walmart WMT.N: Truist Securities raises target price to $98 from $89 |
* Walmart WMT.N: Wells Fargo raises target price to $96 from $90 |
* Walmart WMT.N: UBS raises target price to $100 from $92 |
* Western Midstream Partners LP WES.N: BofA Global Research cuts price objective to $36 from $37 |
* Workhorse Group Inc WKHS.O: TD Cowen raises target price to $1.25 from $0.25 |
* Zeta Global Holdings Corp ZETA.N: Canaccord Genuity raises PT to $28 from $24 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.